FDA inspection
Eurofins CDMO Alphora Inc.: FDA inspection ending Apr 29, 2016
FDA inspection 972749 · No Action Indicated (NAI) · Mississauga
Key facts
| Inspection ID | 972749 |
|---|---|
| Firm | Eurofins CDMO Alphora Inc. |
| FEI number | 3005804912 |
| Address | 2395 Speakman Dr Suite 2001 |
| City | Mississauga |
| Country | Canada |
| Fiscal year | 2016 |
| Inspection end date | Apr 29, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data